Predictive value and accuracy of [(18)F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma

PURPOSE: Immune checkpoint inhibitors (ICIs) are widely used in metastatic melanoma and dramatically alter the treatment of these patients. Given the high cost and potential toxicity, a reliable method for evaluating treatment response is needed. In this study, we assessed tumor response in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayati, Narjess, Jamshidi-Araghi, Zahra, Hoellwerth, Magdalena, Schweighofer-Zwink, Gregor, Hitzl, Wolfgang, Koelblinger, Peter, Pirich, Christian, Beheshti, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317870/
https://www.ncbi.nlm.nih.gov/pubmed/37140669
http://dx.doi.org/10.1007/s00259-023-06247-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317870/
https://www.ncbi.nlm.nih.gov/pubmed/37140669
http://dx.doi.org/10.1007/s00259-023-06247-8

Ejemplares similares